Literature DB >> 32199823

Reoperative Cardiac Surgery Is a Risk Factor for Long-Term Mortality.

Valentino Bianco1, Arman Kilic2, Thomas G Gleason2, Edgar Aranda-Michel1, Andreas Habertheuer3, Yisi Wang3, Forozan Navid2, Alexa Kacin3, Ibrahim Sultan4.   

Abstract

BACKGROUND: Reoperative cardiac surgery has been associated with increased morbidity and mortality. Large propensity-matched series comparing all first-time and redo cardiac operations are lacking. The primary objective of the current study was to provide detailed outcomes and risk factors for mortality and readmissions after reoperative cardiac surgery.
METHODS: All patients who underwent cardiac surgery from 2011 to 2017 were included. Propensity matching yielded equitable cohorts. Multivariable Cox regression analysis was performed to identify independent predictors of 30-day, 1-year, and 5-year mortality and readmissions.
RESULTS: A total of 14,151 patients underwent cardiac surgery, of which 1700 (12%) had reoperative cardiac surgery. There were significantly (P < .001) more comorbidities in the reoperative cardiac surgery group. Propensity matching yielded 1696 patients in each cohort. After propensity matching, operative mortality (8.37% vs 6.07%; P = .01), blood product transfusion (54.7% vs 46.2%; P < .001), and prolonged ventilator requirements (>24 hours) (20% vs 17%; P = .02) were increased for the reoperative cohort. On multivariable analysis for propensity-matched cohorts, reoperation was an independent predictor of mortality at 30 days (hazard ratio [HR], 1.36; 95% confidence interval [CI], 1.05-1.75; P = .02), 1 year (HR, 1.30; 95% CI, 1.09-1.55; P = .004), and 5 years (HR, 1.30; 95% CI, 1.14-1.5; P = .002).
CONCLUSIONS: After risk-adjusting for baseline characteristics, the need for reoperation was an independent predictor of both short-term and long-term mortality after reoperative cardiac surgery. These data are relevant when considering alternative therapies such as percutaneous coronary or transcatheter valve interventions.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32199823     DOI: 10.1016/j.athoracsur.2020.02.028

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Update in Paravalvular Leak Closure.

Authors:  Aken Desai; John C Messenger; Robert Quaife; John Carroll
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

Review 2.  Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions.

Authors:  Dashuai Wang; Yang Lu; Manda Sun; Xiaofan Huang; Xinling Du; Zhouyang Jiao; Fuqiang Sun; Fei Xie
Journal:  Front Cardiovasc Med       Date:  2022-06-30

3.  Nomogram Models to Predict Postoperative Hyperlactatemia in Patients Undergoing Elective Cardiac Surgery.

Authors:  Dashuai Wang; Su Wang; Jia Wu; Sheng Le; Fei Xie; Ximei Li; Hongfei Wang; Xiaofan Huang; Xinling Du; Anchen Zhang
Journal:  Front Med (Lausanne)       Date:  2021-12-02

4.  Permanent pacemaker placement following valve surgery is not independently associated with worse outcomes.

Authors:  Valentino Bianco; Arman Kilic; Edgar Aranda-Michel; Derek Serna-Gallegos; Courtenay Dunn-Lewis; Shangzhen Chen; Floyd Thoma; Forozan Navid; Ibrahim Sultan
Journal:  JTCVS Open       Date:  2021-06-16

5.  Risk Factors for Postoperative Acute Kidney Injury in Patients Undergoing Redo Cardiac Surgery Using Cardiopulmonary Bypass.

Authors:  Can Zhao; Yuntao Li; Guangyu Pan; Jianping Xu; Shen Liu; Yaqiong Xiao
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-29

6.  Retrosternal Deformations after Coronary Artery Bypass Surgery Using Statistical Shape Analysis.

Authors:  Mehmet Senel Bademci; Gokhan Ocakoglu; Cemal Kocaaslan; Fatih Avni Bayraktar; Kaptaniderya Tayfur; Ebuzer Aydin
Journal:  Braz J Cardiovasc Surg       Date:  2021-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.